Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Ontario Genomics Institute Invests in Stem Cell Technology at Tissue Regeneration Therapeutics 

 

 

Ontario Genomics Institute Invests in Stem Cell Technology at Tissue Regeneration Therapeutics

November 12, 2012 - (Ontario Genomics Institute) - "The Ontario Genomics Institute (OGI), through its Pre-Commercialization Business Development Fund (PBDF), has invested in Toronto-based Tissue Regeneration Therapeutics (TRT), a company that aims to use umbilical mesenchymal stem cells (MSCs) to treat a variety of serious medical conditions, such as arthritis, diabetes and Crohn’s disease, to name a few."  Read Full Article

 

Posted on 27-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: